I'm not arguing that tissue concentration of a dru
Post# of 72440
(Total Views: 468)
Posted On: 12/06/2019 9:58:24 AM
I'm not arguing that tissue concentration of a drug over an extended period in the small intestine is the primary and sole factor of GI drug efficiency nor the mechanism of action. However, Theravance Biopharma TD1473 candidate showed a quite noticeable difference in tissue concentration vs Xeijanx (tofactinib).
Why would this data comparison be filed in an SEC document - meaningless?
I'll leave it at that.
Why would this data comparison be filed in an SEC document - meaningless?
I'll leave it at that.
(1)
(0)Innovation Pharmaceuticals Inc (IPIX) Stock Research Links
Scroll down for more posts ▼